Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan

European Journal of Clinical Investigation

Volumn 35, Issue 3, 2005, Pages 214-219

  Inaba, T ^a   Mizuno, M ^b   Take, S ^c   Suwaki, K ^d   Honda, T ^e   Kawai, K ^a   Fujita, M ^a   Tamura, T ^a   Yokota, K ^c   Oguma, K ^c   Okada, H ^c   Shiratori, Y ^c  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b HIROSHIMA CITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d Mitoyo General Hospital   (Japan)

^e TAKAMATSU RED CROSS HOSPITAL   (Japan)

Author keywords

Helicobacter pylori; Idiopathic thrombocytopenic purpura; Multi centre trial

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GLUCOCORTICOID; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DRUG EFFECT; DRUG SAFETY; DUODENUM ULCER; ERADICATION THERAPY; EROSIVE GASTRITIS; EXPERIENCE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMORRHAGIC GASTRITIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; JAPAN; MALE; MULTICENTER STUDY; MYALGIA; OBSERVATION; PATHOGENESIS; PETECHIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; SCAR FORMATION; STOMACH ULCER; TASTE DISORDER; THROMBOCYTE COUNT; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 20044382604     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01471.x     Document Type: Article

References (30)

1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-9.
2. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999;45 (Suppl. 1):I9-I12.
3. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997;103:114-20.
4. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
5. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Stood 2001;97:812-4.
6. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001;115:1002-3.
7. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002;118:584-8.
8. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B et al. Autoimmune thrombocytopenic Purpura and Helicobacter pylori infection. Arch Intern Med 2002;162:1033-6.
9. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004;103:890-6.
10. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
11. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998;42:338-43.
12. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999;44:336-41.
13. Akiyama H, Onozawa Y. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura. Am J Hematol 1998;57:91-2.
14. Tsubakio T, Kurata Y, Yonezawa T, Kitani T. Quantification of platelet-associated IgG with competitive solid-phase enzyme immunoassay. Acta Haematol 1981;66:251-6.
15. Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY. Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection. J Clin Microbiol 1996;34:1147-52.
16. Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med 2002;41:780-3.
17. Nagahara Y, Mizuno M, Maga T, Ishiki K, Okuno T, Yoshida T et al. Outcome of patients with inconsistent results from 13C-urea breath test and bacterial culture at the time of assessment of Helicobacter pylori eradication therapy in Japan. Hepatogastroenterology 2003;50:1700-3.
18. Vianelli N, Valdre L, Fiacchini M, de Vivo A, Gugliotta L, Catani L et al. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 2001;86:504-9.
19. Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T et al. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol 2003;41:1480-5.
20. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-2.
21. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996;111:655-65.
22. Zentilin P, Savarino V, Garnero A, Accardo S, Seriolo B. Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? Gastroenterology 1999;116:503-4.
23. Zentilin P, Seriolo B, Dulbecco P, Caratto E, Iiritano E, Fasciolo D et al. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 2002;16:1291-9.
24. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 1997;5:70-3.
25. Ko GH, Park HB, Shin MK, Park CK, Lee JH, Youn HS et al. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter 1997;2:210-5.
26. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuriyama Y, Gotoh A et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol 2003;77:239-44.
27. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
28. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. Ann Intern Med 1997;126:319-26.
29. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997;126:307-14.
30. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995;98:436-42.